1 INTRODUCTION

    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
    1.3 STUDY SCOPE

        1.3.1 MARKET SEGMENTATION & GEOGRAPHIC SPREAD
        1.3.2 INCLUSIONS & EXCLUSIONS

    1.4 YEARS CONSIDERED
    1.5 CURRENCY CONSIDERED
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 MARKET OVERVIEW

 2.1 INTRODUCTION
 2.2 MARKET DYNAMICS

  2.2.1 DRIVERS
   2.2.1.1 Rising prevalence of cancer
   2.2.1.2 Increasing preference for minimally invasive surgeries
   2.2.1.3 Initiatives undertaken by governments and global health organizations
   2.2.1.4 Increased number of hospitals and diagnostic centers
   2.2.1.5 Improved reimbursement policies

  2.2.2 RESTRAINTS
   2.2.2.1 Increasing product recalls
   2.2.2.2 High risk of infections

  2.2.3 OPPORTUNITIES
   2.2.3.1 Technological advancements
   2.2.3.2 Growing investments in emerging economies

  2.2.4 CHALLENGES
   2.2.4.1 Underdeveloped healthcare infrastructure in emerging economies

 2.3 INDUSTRY TRENDS
  2.3.1 MINIMALLY INVASIVE PROCEDURES
  2.3.2 ROBOTIC-ASSISTED BIOPSY DEVICES
  2.3.3 LIQUID BIOPSY TECHNOLOGY

 2.4 TECHNOLOGY ANALYSIS
  2.4.1 KEY TECHNOLOGIES
   2.4.1.1 Robotic-assisted biopsy devices
   2.4.1.2 Optical biopsy technologies
   2.4.1.3 Minimally invasive biopsy devices

  2.4.2 COMPLEMENTARY TECHNOLOGIES
   2.4.2.1 Imaging technologies
   2.4.2.2 Tissue analysis technologies
   2.4.2.3 Artificial intelligence

  2.4.3 ADJACENT TECHNOLOGIES
   2.4.3.1 Digital pathology and AI integration
   2.4.3.2 Precision medicine tools
   2.4.3.3 Advanced needle and probe technologies

 2.5 PORTER’S FIVE FORCES ANALYSIS
  2.5.1 THREAT FROM NEW ENTRANTS
  2.5.2 BARGAINING POWER OF SUPPLIERS
  2.5.3 BARGAINING POWER OF BUYERS
  2.5.4 THREAT FROM SUBSTITUTES
  2.5.5 INTENSITY OF COMPETITIVE RIVALRY

 2.6 PATENT ANALYSIS
  2.6.1 PATENT PUBLICATION TRENDS IN BIOPSY DEVICES MARKET
  2.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS

 2.7 TRADE ANALYSIS
 2.8 KEY CONFERENCES & EVENTS
 2.9 BIOPSY DEVICES MARKET: UNMET NEEDS/EXPECTATIONS OF END USERS
 2.10 ECOSYSTEM ANALYSIS
 2.11 SUPPLY CHAIN ANALYSIS
 2.12 ADJACENT MARKET ANALYSIS
  2.12.1 BREAST BIOPSY DEVICES MARKET

 2.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 2.14 INVESTMENT & FUNDING SCENARIO
 2.15 IMPACT OF AI ON BIOPSY DEVICES MARKET

3 COMPETITIVE LANDSCAPE
 
 3.1 OVERVIEW
 3.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  3.2.1 Overview of strategies adopted by key players in biopsy devices market

 3.3 REVENUE ANALYSIS
 3.4 MARKET SHARE ANALYSIS
 3.5 COMPANY EVALUATION MATRIX: STARTUPS/SMEs
  3.5.1 PROGRESSIVE COMPANIES
  3.5.2 RESPONSIVE COMPANIES
  3.5.3 DYNAMIC COMPANIES
  3.5.4 STARTING BLOCKS
  3.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMEs

 3.6 COMPANY VALUATION & FINANCIAL METRICS
  3.6.1 COMPANY VALUATION
  3.6.2 FINANCIAL METRICS

 3.7 BRAND/PRODUCT COMPARISON
 3.8 COMPETITIVE SCENARIO
  3.8.1 PRODUCT LAUNCHES & APPROVALS
  3.8.2 DEALS
  3.8.3 EXPANSIONS

4 COMPANY PROFILES

    4.1 MICROPORT SCIENTIFIC CORPORATION

        4.1.1 Business overview
        4.1.2 Products/Solutions/Services offered
        4.1.3 Recent developments

    4.2 ARGON MEDICAL DEVICES

        4.2.1 Business overview
        4.2.2 Products/Solutions/Services offered
        4.2.3 Recent developments

    4.3 INRAD, INC.

        4.3.1 Business overview
        4.3.2 Products/Solutions/Services offered
        4.3.3 Recent developments

    4.4 SUMMIT MEDICAL LLC

        4.4.1 Business overview
        4.4.2 Products/Solutions/Services offered
        4.4.3 Recent developments

    4.5 TRANSMED7, LLC

        4.5.1 Business overview
        4.5.2 Products/Solutions/Services offered
        4.5.3 Recent developments

    4.6 DR. JAPAN CO., LTD

        4.6.1 Business overview
        4.6.2 Products/Solutions/Services offered
        4.6.3 Recent developments

    4.7 IZI MEDICAL PRODUCTS

        4.7.1 Business overview
        4.7.2 Products/Solutions/Services offered
        4.7.3 Recent developments

    4.8 PLANMED OY

        4.8.1 Business overview
        4.8.2 Products/Solutions/Services offered
        4.8.3 Recent developments

    4.9 ADVIN HEALTH CARE

        4.9.1 Business overview
        4.9.2 Products/Solutions/Services offered
        4.9.3 Recent developments

    4.10 TRIVITRON HEALTHCARE

        4.10.1 Business overview
        4.10.2 Products/Solutions/Services offered
        4.10.3 Recent developments